source
- Nine midsize biopharma firms join Trump MFN drug pricing program, covering 89% of branded marketNine midsize biopharma companies have agreed to voluntarily participate in the Trump administration's Most Favored Nation drug pricing program, adding to the 17 large pharmaceutical firms that prev…
- Arsenal Biosciences cuts 99 jobs as it pivots to in-vivo CAR-T therapyArsenal Biosciences announced a major restructuring, laying off 99 employees, which represents the majority of its workforce across all teams and locations. The company is ending development of it…